期刊文献+

MR波谱诊断T3N0M0期前列腺癌冷冻治疗后局部复发的价值 被引量:2

MR spectroscopy in diagnosis of local recurrence of T3N0M0 of prostate cancer after cryotherapy
原文传递
导出
摘要 目的探讨MRS诊断T3N0M0期前列腺癌冷冻治疗后复发的临床价值。方法回顾性分析以行前列腺癌冷冻治疗为主的65例T3N0M0期前列腺癌患者的临床资料。患者冷冻治疗术前均行常规MRI、MRS及病理穿刺活检。术后每个月检测前列腺特异性抗原(PSA)。当PSA升高(〉0.5μg/L)时,于1周内行MRI、MRS及病理活检;如PSA小于0.5μg/L,于术后12个月时行MRI、MRS检查及超声引导下活组织穿刺病理检查。术前根据穿刺活检结果,将前列腺分为癌区和非癌区;通过MRS测量手术前、后前列腺癌癌区和非癌区的胆碱(Cho)、枸橼酸盐(Cit)的信噪比及(Cho+Cre)/Cit[肌酸(Cre)]比值水平。术后复查根据病理活检结果分为无复发组、局部复发组。比较不同分组冷冻治疗前后癌区和非癌区Cho、Cit的信噪比及(Cho+Cre)/Cit比值水平。数据经正态性检验证实为正态分布后,采用独立样本的t检验进行比较。结果(1)术后12个月病理活检证实局部复发患者15例,其中11例PSA在12个月内升高、4例12个月内PSA未见升高。(2)65例患者冷冻治疗前癌区与非癌区Cho峰、Cit峰的信噪比及(Cho+Cre)/Cit比值分别为25±9和11±5,18±5和39±12,2.33±0.60和0.53±0.19,癌区与非癌区比较差异均有统计学意义(t值分别为11.36、9.81和13.39,P值均为0.00)。(3)冷冻治疗后局部未复发的患者,癌区与非癌区的Cho峰、Cit峰的信噪比分别是4±2和3±2(t=1.024,P=0.305),2±2和4±3(t=1.147,P=0.178),癌区与非癌区比较差异无统计学意义;但癌区冷冻治疗术前、后的Cho峰(t=25.22,P=0.00)、Cit峰(t=32.06,P=0.00)和非癌区冷冻治疗前、后的Cho峰(t=17.42,P=0.00)、Cit峰(t=38.60,P=0.00)的信噪比差异均有统计学意义;冷冻治疗术后癌区及非癌区可见有大量坏死区,Cho和Cit的信噪比较低,无法计算(Cho+Cre)/Cit。(4)冷冻治疗后局部复发患者,在癌区和非癌区Cho峰信噪比分别是17±3、3±2(t=17.24,P=0.00),Cit峰的信噪比分别是9±2和3±3(t=23.66,P=0.00),癌区与非癌区比较差异有统计学意义;癌区复发区(Cho+Cre)/Cit的比值与术前相比差异无统计学意义(t=1.214,P=0.256);而非癌区的大量坏死区因Cho峰、Cit峰的信噪比较低,无法计算(Cho+Cre)/Cit。结论MRS可评估前列腺癌冷冻治疗前后治疗局部Cho、Cit的信噪比和(Cho+Cre)/Cit比值水平,有助于判断冷冻治疗后局部复发。 Objective To evaluate the usefulness of magnetic resonance spectroscopic imaging in detecting local recurrence in patients with TaNoM0 prostate cancer after cryotherapy. Methods Sixty-five patients with T3 NO Mo prostate cancer underwent eryotherapy. The preoperative data of conventional MRI, MRS, transrectal ultrasound (TRUS)-guided prostate biopsy were collected. After eryotherapy, the prostatespecific antigen (PSA) of all patients was detected monthly. If PSA 〉 5 μg/L, MRI, MRS, and TRUS- guided prostate biopsy were planned within a week. If PSA was unremarkable, MRI, MRS, and TRUS- guided prostate biopsy were planned 12 months after cryotherapy. The prostate was divided 6 regions and the cancerous and noncancerous were marked. The signal-to-noise ratio(S/N) of choline (Cho), citrate (Cit) and the ratios of Cho + creatine ( Cre )/Cit of each regions were measured in pre-operation and post- operation. The patients were divided into non-recurrence and recurrence group according to TRUS-guided biopsy. The SiN of Cho, Cit, and the ratio of Cho + Cre/Cit were compared between the groups before and after cryotherapy by using independent samples t-test. Results ( 1 ) Fifteen patients were confirmed local recurrence 12 months after cryotherapy, including 11 patients with an evaluate PSA level and 4 patients with PSA unremarkable. (2) The S/N of Cho, Cit and the ratios of Cho + Cre/Cit in the cancerous and noncancerous regions before cryotherapy in the sixty-five patients were 25±9,11±5, and 18±5, and 39 ± 12, 2. 33 ±0. 60, and 0. 53 ±0. 19. There had significant difference between that of two groups (t values were 11.36, 9.81, and 13.39, respectively, P = 0. 00). (3) In the patients with non-recurrence, The S/N of Cho, Cit in the cancerous and noncancerous regions were 4 ± 2 and 3± 2 ( t = 1. 024, P = 0. 305 ), and 2 ±2 and 4 ±3 (t = 1. 147,P =0. 178) and no difference was found. In necrotic area, the ratios of Cho + Cre/Cit could not be calculated because of low level of the S/N of Cho and Cit. (4) In the patients with local recurrence after cryotherapy, the S/N of Cho and Cit in the cancerous and noncancerous regions were 17 ± 3 and 3 ± 2 ( t = 17.24, P = 0. 00), 9 ± 2 and 3 ± 3 ( t = 23.66, P = 0. 00) and a significant difference was found. The ratio of Cho + Cre/Cit in the recurrent area was no significant different compared with that of pre- operation(t=1. 214,P = 0. 256). In necrotic area, the ratios of Cho + Cre/Cit could not be calculated because of low level of the S/N of Cho and Cit. Conclusions MRS is a useful tool to evaluate the changes of the S/N of Cho and Cit, the ratios of the Cho + Cre/Cit and help diagnosis of local recurrence.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2012年第6期529-534,共6页 Chinese Journal of Radiology
基金 国家自然科学基金资助项目(30973438) 国家青年科学基金资助项目(81001002) 天津市应用基础及前沿技术研究计划资助项目(09JCYBJC10400) 天津市卫生局科技基金资助项目(2010R271)
关键词 前列腺肿瘤 磁共振波谱学 冷冻疗法 Prostatic neoplasms Magnetic resonance spectroscopy Cryotherapy
  • 相关文献

参考文献4

二级参考文献41

  • 1张奇夫,孙凯,李娜,刘一,金刚.氩氦刀超低温冷冻术治疗前列腺癌(附18例报告)[J].中国老年学杂志,2006,26(8):1046-1047. 被引量:2
  • 2王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:28
  • 3李景敏,王国佩,霍承瑜,赵宝玉,李宾,陈兵,马依群,潘柏年,郭应禄.超声导向经会阴穿刺冷冻治疗前列腺癌[J].中华泌尿外科杂志,1997,18(7):443-443. 被引量:4
  • 4[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 5[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 6[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 7[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 8[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 9[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 10[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.

共引文献179

同被引文献16

  • 1Baust JG,Gage AA,Bjerklund Johansen TE,et al.Mechanisms of cryoablation:clinical consequences on malignant tumors[J].Crvobiology 2014,68:1-11.
  • 2A1 Ekish S,Nayeemuddin M,Maddox M,et al.The role of cryosurgery of the prostate for nonsurgical candidates[J].JSLS,2013,17:423-428.
  • 3Ullal AV,Korets R,Katz AE,et al.A report on major complications and biochemical recurrence after primary and salvage cryosurgery for prostate cancer in patients with prior resection for benign prostatic hyperplasia:a single-center experience[J].Urology,2013,82:648-652.
  • 4Quarrier S,Katz A,Haas J.Treatment of prostate cancer local recurrence after whole-gland cryosurgery with frameless robotic stereotactic body radiotherapy:initial experience[J].Clin Genitourin Cancer,2013,11:89-93.
  • 5Wenske S,Quarrier S,Katz AE.Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery:long-term clinical,functional,and oncologic outcomes in a large cohort at a tertiary referral centre[J].Eur Uro1,2013,64:1-7.
  • 6Johnson LM,Turkbey B,Figg WD,et al.Multiparametric MRI in prostate cancer management[J].Nat Rev Clin Oncol,2014,11:346-353.
  • 7Alonzo DG,Mure AL,Soloway MS.Prostate cancer and the increasing role of active surveillance[J].Postgrad Med,2013,125:109-116.
  • 8Narayanan G,Froud T,Lo K,et al.Pain analysis in patients with hepatocellular carcinoma:irreversible electroporation versus radiofrequency ablation-initial observations[J].Cardiovasc Intervent Radiol,2013,36:176-182.
  • 9Ng KM,Chua TC,Saxena A,et al.Two decades of experience with hepatic cryotherapy for advanced colorectal metastases[J].Ann Surg Oncol,2012,19:1276-1283.
  • 10Kim CK,Park BK,Lee HM,et al.MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer[J].AJR Am J Roentgenol,2008,190:1180-1186.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部